Clinical Endocannabinoid Deficiency was a theory posited by Dr. Russo back in 2001 in which he theorized that low endocannabinoid levels could be behind a range of chronic conditions such as IBS, fibromyalgia, migraines, and other treatment-resistant syndromes. Dr. Russo suggested that because these conditions are all developed over time, rather than congenitally, and that they could be a result of disturbances to the ECS. This also means there’s a possibility of reversing them.
The first episode of Jerry Chu’s new long-form video podcast, produced with En Volá and…
The engine is Gen Z. Analytics firm Headset found that over the past year of…
The AEW star gets candid about loss, love, life on the road, and the role…
Sara Carter, the former investigative journalist and Fox News contributor now serving as White House…
Weed may be legal in much of America, but for non-citizens, one hit, one job,…
A new survey conducted by Pew Research examined what is considered “morally acceptable” in 25 countries.…